<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Retrovirology</journal-id><journal-id journal-id-type="iso-abbrev">Retrovirology</journal-id><journal-title-group><journal-title>Retrovirology</journal-title></journal-title-group><issn pub-type="epub">1742-4690</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3558390</article-id><article-id pub-id-type="publisher-id">1742-4690-9-111</article-id><article-id pub-id-type="pmid">23253934</article-id><article-id pub-id-type="doi">10.1186/1742-4690-9-111</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Santoni</surname><given-names>Federico A</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>federico.santoni@unige.ch</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Guerra</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jessica.guerra@unige.ch</email></contrib><contrib contrib-type="author" corresp="yes" id="A3"><name><surname>Luban</surname><given-names>Jeremy</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>jeremy.luban@umassmed.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Genetic Medicine and Development, University of Geneva, 1 rue Michel-Servet, Geneva, CH-1211, Switzerland</aff><aff id="I2"><label>2</label>Department of Microbiology and Molecular Medicine, University of Geneva, 1211, Geneva 4, Switzerland</aff><aff id="I3"><label>3</label>Program in Molecular Medicine and Biochemistry &#x00026; Molecular Pharmacology, University of Massachusetts Medical School, 373 Plantation Street, Biotech 2, Suite 319, Worcester, MA, 01605, USA</aff><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2012</year></pub-date><volume>9</volume><fpage>111</fpage><lpage>111</lpage><history><date date-type="received"><day>5</day><month>12</month><year>2012</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2012 Santoni et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>Santoni et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.retrovirology.com/content/9/1/111"/><abstract><sec><title>Background</title><p>Certain post-translational modifications to histones, including H3K4me3, as well as binding sites for the transcription factor STAT1, predict the site of integration of exogenous gamma-retroviruses with great accuracy and cell-type specificity. Statistical methods that were used to identify chromatin features that predict exogenous gamma-retrovirus integration site selection were exploited here to determine whether cell type-specific chromatin markers are enriched in the vicinity of endogenous retroviruses (ERVs).</p></sec><sec><title>Results</title><p>Among retro-elements in the human genome, the gamma-retrovirus HERV-H was highly associated with H3K4me3, though this association was only observed in embryonic stem (ES) cells (p&#x02009;&#x0003c;&#x02009;10<sup>-300</sup>) and, to a lesser extent, in induced pluripotent stem (iPS) cells. No significant association was observed in nearly 40 differentiated cell types, nor was any association observed with other retro-elements. Similar strong association was observed between HERV-H and the binding sites within ES cells for the pluripotency transcription factors NANOG, OCT4, and SOX2. NANOG binding sites were located within the HERV-H 5<sup>&#x02032;</sup>LTR itself. OCT4 and SOX2 binding sites were within 1 kB and 2 kB of the 5<sup>&#x02032;</sup>LTR, respectively. In keeping with these observations, HERV-H RNA constituted 2% of all poly A RNA in ES cells. As ES cells progressed down a differentiation pathway, the levels of HERV-H RNA decreased progressively. RNA-Seq datasets showed HERV-H transcripts to be over 5 kB in length and to have the structure 5<sup>&#x02032;</sup>LTR-<italic>gag</italic>-<italic>pro</italic>-3<sup>&#x02032;</sup>LTR, with no evidence of splicing and no intact open reading frames.</p></sec><sec><title>Conclusion</title><p>The developmental regulation of HERV-H expression, the association of HERV-H with binding sites for pluripotency transcription factors, and the extremely high levels of HERV-H RNA in human ES cells suggest that HERV-H contributes to pluripotency in human cells. Proximity of HERV-H to binding sites for pluripotency transcription factors within ES cells might be due to retention of the same chromatin features that determined the site of integration of the ancestral, exogenous, gamma-retrovirus that gave rise to HERV-H in the distant past. Retention of these markers, or, alternatively, recruitment of them to the site of the established provirus, may have acted post-integration to fix the provirus within the germ-line of the host species. Either way, HERV-H RNA provides a specific marker for pluripotency in human cells.</p></sec></abstract><kwd-group><kwd>HERV-H</kwd><kwd>Endogenous retrovirus</kwd><kwd>Pluripotency</kwd><kwd>Long non-coding RNA</kwd><kwd>Embryonic stem cell</kwd><kwd>Induced pluripotent stem cell</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Vertebrate genomes contain retroviral sequences that are believed to be remnants of exogenous retroviral infection from the distant past [<xref ref-type="bibr" rid="B1">1</xref>]. The genesis of these endogenous retroviruses (ERVs) necessitates establishment of provirus by the ancestral, exogenous retrovirus within host germ cells, such that these elements are maintained as heritable genetic elements in the host species. Human endogenous retroviruses (HERVs) are not uncommon, and account for at least 8% of the total human DNA. By comparison with DNA sequences from exogenous retrovirus families, three main classes of HERVs, gamma, beta, and delta have been identified [<xref ref-type="bibr" rid="B2">2</xref>]. Phylogenetic analyses identified HERV-K, a betaretrovirus, and HERV-H, a gammaretrovirus, as the most recent entries into the genomes of primates, 10 and 25 million years ago, respectively [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>].</p><p>Though some HERVs are transcriptionally active, most retroviral sequences in the human genome are corrupted by mutations or successive insertion of transposable elements; most HERVs lack intact open reading frames for viral protein production and no autonomously replicating HERV has been identified. As a result, HERVs are generally considered non-functional, junk DNA. In some cases, though, HERVs make significant - even essential - contributions to the normal physiology of the host species [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. HERVs have also been implicated in the development of pathological conditions [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. Interestingly, HERVs can be activated by exogenous retrovirus infection [<xref ref-type="bibr" rid="B15">15</xref>] and, in reciprocal fashion, the immune response to these elements can influence the outcome of infection by pathogenic, exogenous retroviruses such as HIV-1 [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>].</p><p>Exogenous retroviruses integrate into locations throughout the host chromosomal DNA in a quasi-random fashion (reviewed extensively in [<xref ref-type="bibr" rid="B18">18</xref>]). Previously, we developed statistical tools to identify association between the sites of provirus establishment and chromosome marks &#x02013; as determined by chromatin immuno-precipitation with massively parallel DNA sequencing (ChIPSeq) [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. From this analysis we identified chromatin modifications (H3K4me3, H3K4me1, and H3K9ac) and binding sites for transcription factors (STAT1) that predict the site of integration for gamma-retroviruses with great accuracy in a cell-type specific manner [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Precise markers such as these were not identified for other classes of retrovirus such as the lentivirus HIV-1 [<xref ref-type="bibr" rid="B18">18</xref>]. Here, the same statistical methods were exploited to determine whether any ERVs retain association with cell type-specific chromatin features that might have determined the site of integration in the distant past, or that served to fix the provirus in the genetic patrimony of the host species.</p></sec><sec sec-type="results"><title>Results</title><sec><title>Search for chromatin features near the site of ERVs</title><p>Previously observed, high-level association between gamma-retrovirus integration sites and particular epigenetic markers [<xref ref-type="bibr" rid="B18">18</xref>] prompted a quest to find association between any known endogenous retroviral element in the human and mouse genomes, and the cell-type specific localization of particular chromosomal features. For this purpose, ChIPSeq profiles were evaluated from more than 40 different human and mouse cell types, including ES cells, iPS cells, monocytes, HeLa cells, CD4+ T cells, and CD34<sup>+</sup> hematopoietic cells (Table <xref ref-type="table" rid="T1">1</xref>). H3K4me3 was used in the initial analysis because of the availability of ChIPSeq datasets from a large number of cell types for this marker. The ERV dataset was compiled using all endogenous, LTR-containing elements annotated via RepeatMasker on the human reference genome hg18 (UCSC) or the mouse reference genome mm9 (UCSC).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Data used for analysis of endogenous retroviruses</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th align="left"><bold>Data type GEO accession number</bold></th><th align="left"><bold>Factor</bold></th><th align="left"><bold>Cell type or tissue</bold></th><th align="left"><bold>Reference</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><bold>Human</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">ChIPSeq, GSE16256<hr/></td><td align="left" valign="bottom">H3K4me3, H3K27me3<hr/></td><td align="left" valign="bottom">H1, H9, I3, iPS, IMR90<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B20">20</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">ChIPSeq, GSE22499<hr/></td><td align="left" valign="bottom">H3K4me3<hr/></td><td align="left" valign="bottom">BG01/03, WIBR1/2/7, hiPSA6/C1, Fibroblast<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B21">21</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">ChIPSeq, GSE15353<hr/></td><td align="left" valign="bottom">H3K4me3<hr/></td><td align="left" valign="bottom">HeLa w/o IFN<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B22">22</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">ChIPSeq, GSE19465<hr/></td><td align="left" valign="bottom">H3K4me3<hr/></td><td align="left" valign="bottom">hiPS-11a/18c/15b/20b, duodenum mucosa, BM-MSC,smooth muscle, adult liver, fetal lung, fetal brain, CD34, CD3, CD15, CD19, Pancreatic Islets<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B23">23</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">ChIPSeq, GSE20650<hr/></td><td align="left" valign="bottom">NANOG,OCT4, KLF4<hr/></td><td align="left" valign="bottom">H1<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B24">24</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">ChIPSeq, GSE18292<hr/></td><td align="left" valign="bottom">SOX2<hr/></td><td align="left" valign="bottom">H1<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B25">25</xref>]<hr/></td></tr><tr><td align="left" valign="bottom">RNASeq, GSE23316<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">H1, HeLa, K562<hr/></td><td align="left" valign="bottom">UCSC ENCODE Project<hr/></td></tr><tr><td align="left" valign="bottom">RNASeq, GSE20301<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">H1, differentiated H1<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B26">26</xref>]<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Mouse</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="left" valign="bottom">ChIPSeq, GSE22075<hr/></td><td align="left" valign="bottom">Mouse H3K4me3<hr/></td><td align="left" valign="bottom">ES, LSK cells<hr/></td><td align="left" valign="bottom">[<xref ref-type="bibr" rid="B27">27</xref>]<hr/></td></tr><tr><td align="left">ChIPSeq, GSE12241</td><td align="left">Mouse H3K4me3</td><td align="left">ES, MEF</td><td align="left">[<xref ref-type="bibr" rid="B28">28</xref>]</td></tr></tbody></table></table-wrap><p>Figure <xref ref-type="fig" rid="F1">1</xref> shows this analysis schematically. The block <italic>Associator</italic> is a computational module fed by ChIPSeq profiles and LTR loci. Among all LTRs, only HERV-H showed a significant association with H3K4me3, though this association was only with some human cell types; the location of the endogenous gamma-retrovirus was associated with H3K4me3 profiles in ES cells (F-score &#x0003e;0.8; p&#x02009;&#x0003c;&#x02009;10<sup>-300</sup>, by Fisher exact test) and, to a lesser extent, in iPS cells (F-score &#x0003e;0.7; p&#x02009;&#x0003c;&#x02009;10<sup>-100</sup>). F-scores&#x02009;&#x0003e;&#x02009;0.5 are considered significant with 1.0 maximal [<xref ref-type="bibr" rid="B18">18</xref>], so these values are highly significant. In contrast, no retroviral element in the mouse was found to be associated with H3K4me3.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Schematic showing the strategy for detecting association between endogenous retro </bold><bold>elements and the H3K4me3 marker.</bold> H3K4me3 CHiPSeq data for more than 40 different cell types were checked for association within 2 kB of all annotated endogenous retroviral elements (hg18) using methods described in reference [<xref ref-type="bibr" rid="B18">18</xref>]. Only HERV-H proviruses showed association with H3K4me3, and this was only significant in human ES cell lines. No association between H3K4me3 and endogenous retro-elements was detected in the mouse.</p></caption><graphic xlink:href="1742-4690-9-111-1"/></fig><p>The data were assessed by means of Hierarchical Clustering. Each association profile was calculated as a function of the distance between HERV-H and the nearest H3K4me3 marker, discretized with steps of 0.5 kB. The specific cells are listed on the x axis of Figure <xref ref-type="fig" rid="F2">2</xref>, and the window size in kilobases is shown on the y-axis. The Euclidean distance between these profiles was used to discriminate among clusters. The algorithm identified three main clusters of high, medium and low association (represented in red, green and blue in Figure <xref ref-type="fig" rid="F3">3</xref>). The cluster with the highest association (red) was populated by ES cells (H1, H9 and I3) and iPS cells (iPS-15b and iPS-11a), with a mean F score of 0.74. The cluster with medium association (green) was populated by bone marrow mesenchymal stem cells (DMSC), breast cancer cells (vHMEC), fetal lung cells and fetal brain cells; it had F scores that were just barely significant. Some iPS cells (A6, PDB1lox, 18c, C1) fall within this cluster, thus confirming that many iPS cells have epigenetic profiles distinct from those of ES cells [<xref ref-type="bibr" rid="B29">29</xref>]. The blue cluster consisted of differentiated cells, including CD4<sup>+</sup> T cells, fibroblasts, pancreatic islet cells, and HeLa cells; the mean F score of 0.36 was insignificant. The association of HERV-H with the post-translational histone modification H3K4me3 correlated strongly with the degree of cell differentiation, a relationship that was clearly visible using chromosome projection mandalas (Figure <xref ref-type="fig" rid="F4">4</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>H3K4me3 association with HERV</bold>-<bold>H proviruses, as measured with the F score, in 40 different cell types, as a function of the distance from the marker.</bold> The F score is reported on the z-axis. Cell types are listed on the x-axis, while the window size is reported on the y-axis. Yellow to red bands indicate a significant association (F score &#x0003e;0.5). Significance decreases as the color shifts from red to blue. 12 out of 15 of the cell types with significant F scores are either human ES cells or iPS cells.</p></caption><graphic xlink:href="1742-4690-9-111-2"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Hierarchical cluster analysis of the HERV-H/H3K4me3 F score, as a function of the window size (horizontal axis).</bold> F score is represented using the color scale as in Figure <xref ref-type="fig" rid="F2">2</xref>. The highly associated cluster (red tree) was made of human ES and iPS cells. The cluster with medium association (green) consisted of mesenchymal stem cells (DMSC), fetal lung and brain cells, and some iPS cells, with F scores that were barely significant. The blue cluster consisted of differentiated cells and the mean F score of 0.36 was insignificant.</p></caption><graphic xlink:href="1742-4690-9-111-3"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Chromosome projection mandalas showing the proximity of each HERV-H provirus to the nearest site of H3K4Me3 on the chromosome, in human I3 ES cells, iPS-15b cells, and HeLa cells.</bold> Each dot on the mandala indicates an HERV-H provirus, as described in reference [<xref ref-type="bibr" rid="B18">18</xref>]. The angular distance around the mandala indicates the linear position of each provirus on the indicated chromosome. The radial distance from the perimeter indicates the distance of the provirus from the nearest H3K4Me3 site, in log scale from 0 to 1 megabase. Blue dots are HERV-H proviruses within 2 kB from the nearest marker. Red dots are proviruses &#x0003e;2 kB away from the nearest H3K4Me3 site. The association strength (F score) is written under each Mandala. F score&#x02009;&#x0003e;&#x02009;0.5 constitutes a significant association.</p></caption><graphic xlink:href="1742-4690-9-111-4"/></fig></sec><sec><title>HERV-H expression in ES cells</title><p>Given the remarkable, pluripotent stem cell-specific association of HERV-H with H3K4me3, a marker for transcriptionally active promoters [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>], HERV-H expression would be expected to be higher in ES and iPS cells than in differentiated cell types. Consistent with this possibility, HERV-H was not associated with H3K27me3 (F score 0.2), a marker for transcriptional repression in ES cells [<xref ref-type="bibr" rid="B32">32</xref>]. ENCODE Project RNA-seq data sets [<xref ref-type="bibr" rid="B33">33</xref>] of paired 75 nucleotide reads from human ES cells and 6 differentiated cell types were assessed for HERV-H RNA peaks. In H1 human ES cells, HERV-H RNA accounted for 2% of the total RNA. This extraordinary level of HERV-H expression was confirmed with RNA-seq data [<xref ref-type="bibr" rid="B34">34</xref>] from H9, another ES cell line. For comparison, expression of the younger and better-conserved beta-retrovirus HERV-K was 1000-fold lower than HERV-H in H1 ES cells. HERV-H RNA was 100-lower in HeLa cells and more than 100-fold lower in K562 myelogenous leukemia cells, GSM12878 lymphoblastoid cells, HepG2 hepatocellular liver carcinoma cells, human umbilical vein endothelial cells (HUVEC), and NHEK epidermal keratinocytes. BRD2, a gene that is expressed at nearly the same level in all these cell types was 25-fold lower in expression than HERV-H in ES cells (Figure <xref ref-type="fig" rid="F5">5</xref>).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Cumulative expression of all HERV-H proviruses in human H1 ES cells (hESC), HeLa cells, or K562 cells, compared to expression of HERV-K and BRD2, a constitutive gene with the same expression level in all three cell types.</bold> In human ES cells, HERV-H is expressed 1000-fold higher than HERV-K and 25-fold higher than BRD2. HERV-H expression is barely detectable in HeLa, and no significant HERV-H expression was detected in K562 cells. RNASeq data for this analysis were from reference [<xref ref-type="bibr" rid="B33">33</xref>].</p></caption><graphic xlink:href="1742-4690-9-111-5"/></fig><p>Almost all the HERV-H RNA expressed in ES cells had the structure 5<sup>&#x02032;</sup>LTR-<italic>gag</italic>-<italic>pro</italic>-3<sup>&#x02032;</sup>LTR with deletion of the <italic>pol</italic> and <italic>env</italic> regions, and no intact open reading frames. HERV-H fragments containing <italic>pol</italic> and <italic>env</italic> sequences were barely detected (Figure <xref ref-type="fig" rid="F6">6</xref>).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Mapping of RNA-seq reads from H1 human ES cells on a schematic of the HERV-H provirus.</bold> The quantity of each RNA read was normalized to the reads corresponding to the 5<sup>&#x02032;</sup> LTR. Only RNA fragments corresponding to 5<sup>&#x02032;</sup>LTR-<italic>gag</italic>-<italic>pro</italic>-3<sup>&#x02032;</sup>LTR were expressed to a significant level in human ES cells.</p></caption><graphic xlink:href="1742-4690-9-111-6"/></fig><p>It has been reported that human ES cell DNA is hypo-methylated with respect to differentiated cell lines, and that this global effect releases all endogenous elements, such as SINEs, LINEs, and HERVs, from transcriptional silencing [<xref ref-type="bibr" rid="B35">35</xref>]. To determine if HERV-H expression in ES cells is simply a result of this global trend, the RNA-seq data was used to compare the expression level of all repetitive elements in ES cells. Compared to LINEs and SINEs, HERV-H was by far the most expressed repetitive element in human ES cells, accounting for nearly all transcription of the HERV family (Figure <xref ref-type="fig" rid="F7">7</xref>).</p><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>HERV-H expression accounts for nearly all HERV expression in human ES cells and is a not a non-specific consequence of wide-spread hypo-methylation in these cells.</bold> Quantitation of the RNA-seq reads from H1 ES cells, broken down according to the LINES, SINES, all HERVs, the nearly 1,000 HERV-H proviruses, and conventional genes. HERV-H RNA accounted for nearly all the HERV RNA in human ES cells, and 2% of total RNA. Specific vs. non-specific expression was determined by comparing the expression level of each element to the surrounding sequences.</p></caption><graphic xlink:href="1742-4690-9-111-7"/></fig><p>It is also important to consider that expression of endogenous retro-elements might be influenced by local effects from adjacent transcriptional units. The difference between the expression level of the repetitive elements and the expression level of the surrounding sequences was assessed (see Methods for details). By this measure, HERV-H exhibited transcriptional specificity comparable to that of conventional genes, in terms of specific/unspecific transcription ratio (0.85 vs. 0.86), while LINEs and SINEs had a transcription ratio of 0.06 and 0.03, respectively (Figure <xref ref-type="fig" rid="F7">7</xref>).</p></sec><sec><title>HERV-H expression over the course of human ES cell differentiation</title><p>The disparity between the high transcriptional level of HERV-H in human ES cells, and the near absence of HERV-H transcription in differentiated cells prompted an assessment of HERV-H expression as ES cells differentiate. To accomplish this, raw data was analyzed from a 4-point time course experiment (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20301">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20301</ext-link>) in which RNA was collected from human ES cells in the undifferentiated state (N0), early initiation (N1), neural progenitor (N2), and pre-glial cell (N3) stages [<xref ref-type="bibr" rid="B26">26</xref>]. High HERV-H transcriptional levels were confirmed in the undifferentiated N0 stage, and HERV-H levels decreased progressively with a magnitude that correlated with the differentiation time-point (Figure <xref ref-type="fig" rid="F8">8</xref>).</p><fig id="F8" position="float"><label>Figure 8</label><caption><p><bold>HERV-H expression correlates with differentiation status.</bold> HERV-H expression as H1 human ES cells differentiate down a pathway towards neural progenitors and early glial cells. Black bars indicate unspecific expression; white bars represent specific expression, adjusted for expression as described in Figure <xref ref-type="fig" rid="F7">7</xref>. BRD2 has the same expression level at each stage of differentiation and was used to normalize HERV-H RNA levels.</p></caption><graphic xlink:href="1742-4690-9-111-8"/></fig></sec><sec><title>HERV-H and pluripotency transcription factors</title><p>When ectopically expressed in particular combinations, the transcription factors NANOG, OCT4, and SOX2 are capable of reprogramming mature somatic cells into pluripotent stem cells [<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B39">39</xref>]. Conversely, the expression of these factors decreases as cells differentiate [<xref ref-type="bibr" rid="B40">40</xref>]. The RNA-seq data sets utilized above that measure the dynamics of RNA in ES cells as they differentiate into neural progenitors was analyzed for expression of HERV-H and for these transcription factors. HERV-H RNA levels correlated well with those of NANOG and OCT4 (Figure <xref ref-type="fig" rid="F9">9</xref>). SOX2 was more stably expressed during differentiation than was NANOG or OCT4 and its expression did not correlate with that of HERV-H.</p><fig id="F9" position="float"><label>Figure 9</label><caption><p><bold>HERV-H expression levels correlate with those of pluripotency transcription factors NANOG and OCT4 as human ES cells move down a differentiation pathway.</bold> N0, undifferentiated ES cells. N1, early initiation stage of differentiation. N2, neural progenitor stage. OCT4 and NANOG are positively correlated with HERV-H (&#x003c1;&#x02009;=&#x02009;0.95, &#x003c1;&#x02009;=&#x02009;0.84, respectively). SOX2 shows no correlation.</p></caption><graphic xlink:href="1742-4690-9-111-9"/></fig><p>To explore the possibility that these pluripotency transcription factors are somehow involved in HERV-H transcription, an association analysis was conducted between HERV-H locations and the ChIPSeq binding profiles of NANOG, OCT4, SOX2, and KLF4 extracted from ES cells [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>] (Figure <xref ref-type="fig" rid="F10">10</xref>). Over a 2 kB window, NANOG showed the most significant association (F score 0.75, p&#x02009;&#x0003c;&#x02009;10<sup>-180</sup>). OCT4 weakly associated with HERV-H (F score 0.55, p&#x02009;&#x0003c;&#x02009;0.0001), while SOX2 and KLF4 were not associated (F score 0.46 and 0.24, respectively).</p><fig id="F10" position="float"><label>Figure 10</label><caption><p><bold>Modified chromosome projection mandalas depicting NANOG, OCT4, SOX2 and KLF4 associations with HERV-H proviruses.</bold> Mandalas were generated as described in reference [<xref ref-type="bibr" rid="B18">18</xref>] and Figure <xref ref-type="fig" rid="F4">4</xref> above. The green ring indicates the HERV-H 5<sup>&#x02032;</sup> LTR region (500 nucleotides from the transcriptional start site). Dot size is proportional to the expression level of each single provirus. NANOG is bound to the 5<sup>&#x02032;</sup>LTR of almost all highly expressed retroviruses. OCT4 shows a significant association. SOX2 binds all expressed HERV-H in a region between 1 KB and 2 KB while KLF4 does not show any significant association pattern.</p></caption><graphic xlink:href="1742-4690-9-111-10"/></fig><p>Statistical significance increased considerably when the expression level of individual HERV-H proviruses was monitored (Figure <xref ref-type="fig" rid="F11">11A</xref> and B). As visualized on the chromosome projection mandala in Figure <xref ref-type="fig" rid="F11">11C</xref>, NANOG binds to the LTRs of 96% of the 50 most highly expressed HERV-H proviruses. These 50 proviruses account for 80% of all HERV-H RNA. The LTR region corresponding to the first 0.5 kB of HERV-H proviral sequence is highlighted in green, with dot sizes proportional to expression levels. With a window of 0.5 kB, the F score for NANOG was nearly perfect (0.97, p&#x02009;&#x0003c;&#x02009;10<sup>-300</sup>). Limited to this subset of HERV-H proviruses the F scores for OCT4 (0.90 wi2kB, p&#x02009;&#x0003c;&#x02009;10<sup>-300</sup>) and SOX2 (0.85 wi4kB; p&#x02009;&#x0003c;&#x02009;10<sup>-300</sup>) were also tightly linked to HERV-H. KLF4, in contrast, was not associated with HERV-H (F score 0.34). The average distance of the NANOG, OCT4 and SOX2 ChIPSeq peaks from the HERV-H transcription start sites was 250 basepairs, 1 kB and 2 kB, respectively, as if these factors were uniformly distributed along the HERV-H promoter in human ES cells (Figure <xref ref-type="fig" rid="F11">11B</xref>). Indeed, for 80% of the highly expressed HERV-H proviruses NANOG, OCT4 and SOX2 map in this order.</p><fig id="F11" position="float"><label>Figure 11</label><caption><p><bold>Ordered spacing of pluripotency transcription factors, binding to the HERV-H 5<sup>&#x02032;</sup> LTR in human ES cells.</bold> (<bold>A</bold>) Association strength (F score) of NANOG, OCT4 and SOX2 binding sites with the 50 most highly expressed HERV-H proviruses (accounting for 80% of total HERV-H expression), as a function of distance from the HERV-H transcription start site (TSS). Maxima in F score indicate the distance of greatest association. (<bold>B</bold>) Average distance of NANOG (red), OCT4 (blue) and SOX2 (green) to HERV-H TSS is shown schematically. As expected from a uniform distribution model, the average distance is half of the distance between maximal association and TSS. (<bold>C</bold>) Chromosome Projection Mandala combining NANOG, OCT4 and SOX2 with respect to 50 HERV-H proviruses. The three embryonic transcription factors bind with the same order (NANOG-OCT4-SOX2) to the promoter region of the most expressed HERV-Hs.</p></caption><graphic xlink:href="1742-4690-9-111-11"/></fig></sec><sec><title>Association of LINE elements with NANOG in human ES cells</title><p>As a matter of comparison, a chromosome projection mandala was created in which NANOG binding sites in ES cells were compared with the location of the LINEs (Figure <xref ref-type="fig" rid="F12">12</xref>). Only one LINE, located on chromosome 13 between nucleotides 55,048,158 and 55,050,476, was expressed to an appreciable level. Interestingly, a deeper inspection of this region revealed a particular genomic structure where LINE transcription was driven by an adjacent HERV-H, bounded by NANOG binding sites at both LTRs. This element does not have an intact ORF, and its functional role is unclear. It is also noteworthy that the adjacent HERV-L is not expressed, even if it is immediately adjacent to the transcribed region, confirming that HERV-H expression is not a non-specific consequence of hypomethylation in ES cells.</p><fig id="F12" position="float"><label>Figure 12</label><caption><p><bold>(A) Chromosome projection mandala depicting the association between NANOG and expressed LINEs in human ES cells.</bold> Only one LINE (large blue dot on chromosome 13) was expressed to high level in these cells. (<bold>B</bold>) The genomic region around the LINE on chromosome 13 is shown with the UCSC Genome Browser, where the linear chromosome is mapped on the horizontal axis. The position of the adjacent HERV-H and HERV-L proviruses is shown. Four biological replicates confirm HERV-H and LINE expression in human ES cells while no expression was detected in K562 cells (only one of the 4 replicates is shown). The direction of transcription was determined by strand-specific sequencing [<xref ref-type="bibr" rid="B33">33</xref>]. NANOG bound to both LTRs (represented with black squares along the LTR row) in the adjacent HERV-H. The adjacent HERV-L was not transcribed.</p></caption><graphic xlink:href="1742-4690-9-111-12"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>This study discovered a strong association between the genomic location of HERV-H proviruses and H3K4me3-modified histones, that is exclusive to human ES and some iPS cells. Consistent with H3K4me3 serving as a marker for active transcription, HERV-H expression was high in these pluripotent stem cells. Moreover, the pluripotency transcription factors NANOG, OCT4 and SOX2 bound to the LTRs of transcriptionally active HERV-H proviruses, or within 2 kB of them. NANOG, OCT4 and SOX2 frequently co-occupy the promoters of target genes, many of which are transcription factors that regulate development such as homeodomain proteins [<xref ref-type="bibr" rid="B41">41</xref>].</p><p>These observations strongly support the hypothesis that HERV-H transcripts play a role in human pluripotency and that this role is finely regulated by three of the most important transcription factors in ES cells. In addition to the binding of NANOG, OCT4, and SOX2 to the HERV-H promoter, HERV-H RNA decreased as ES cells differentiated, in a manner that was proportional to the expression of NANOG and OCT4. Conversely, HERV-H RNA was undetectable in primary fibroblasts but increased enormously after forced re-programming to generate pluripotent stem cells (unpublished data provided by Audrey Letourneau and Stylianos Antonarakis). HERV-H, then, can be exploited as a reliable marker of ES cell pluripotency, as well as an indicator of the degree of &#x0201c;stemness&#x0201d; of iPS cells as they are generated from fibroblasts.</p><p>HERV-H transcripts are 5 to 6 kB in length and lack open reading frames. We can only speculate about the function of these lncRNAs. They might, for example, serve to soak-up miRNAs that promote differentiation, as has been shown with linc-MD1 in muscle differentiation [<xref ref-type="bibr" rid="B42">42</xref>] or the <italic>PTENP1</italic> pseudogene in the regulation of PTEN and growth suppression [<xref ref-type="bibr" rid="B43">43</xref>]. They might bind to chromatin and act as a scaffold for the local recruitment of pluripotency transcription factors, similar to other lncRNAs like HOTAIR for histone modification complexes [<xref ref-type="bibr" rid="B44">44</xref>] and Xist in the context of X-chromosome inactivation [<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B46">46</xref>]. Alternatively, HERV-H might counteract retrovirus spread by interfering with packaging of retroviral genomic RNA [<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>] or by soaking up miRNAs that are required for retrovirus transduction.</p><p>The study here failed to identify chromatin markers that associate with endogenous retro-elements in mice. This was somewhat surprising given the many endogenous retro-elements in this species, including endogenous gamma-retroviruses, some of which are intact and functional [<xref ref-type="bibr" rid="B8">8</xref>]. It was also surprising because exogenous gamma-retroviruses have the same integration site preferences in mouse cells as they have in human cells [<xref ref-type="bibr" rid="B18">18</xref>]. MLV integration sites are associated with the H3K4me3 profile in mouse embryonic fibroblasts (F score&#x02009;=&#x02009;0.83; p&#x02009;&#x0003c;&#x02009;10<sup>-100</sup>). Similar results with murine hematopoietic stem cells (F score of 0.81; p&#x02009;&#x0003c;&#x02009;10<sup>-100</sup>) indicate that, as in human cells, the association strength is cell-type dependent.</p><p>One possible explanation for the failure to identify chromatin markers associated with endogenous murine retroviruses is species-specific differences in the recruitment of the transcriptional silencing machinery. In murine ES cells, for example, a sequence-specific DNA-binding protein, ZNF809 [<xref ref-type="bibr" rid="B49">49</xref>], recruits TRIM28 and other components of the cellular machinery that silence MLV [<xref ref-type="bibr" rid="B50">50</xref>]. ZNF809 has no orthologue in humans; perhaps ZNF809 arose as a result of selective pressure exerted by murine specific gamma-retroviruses during evolution.</p><p>Previous work demonstrated that when exogenous retroviruses integrate they home to sites of H3K4me3 [<xref ref-type="bibr" rid="B18">18</xref>]. Similarly, the association of endogenous gamma-retrovirus HERV-H with H3K4me3 suggests that when human and simian germ cells were bombarded with the HERV-H ancestor 15 to 30 millions years ago, these ancient retroviruses integrated in proximity to H3K4me3-marked chromatin. These proviruses might then have retained these cell-type specific marks as they became fixed in the primate genome. Alternatively, unmethylated HERV-H LTRs might have recruited chromatin remodeling factors and induced H3K4me3 modification of the viral promoter after integration had occurred.</p><p>Analysis of the DNA surrounding HERV-H proviruses failed to clarify which of these two scenarios is more likely. Additionally, search for epigenetic markers like H3K4me3 in syntenic regions in the mouse genome was attempted to determine if these chromatin marks are conserved across the species and predate the entry of HERV-H into the primate genome. DNA surrounding HERV-H proviruses in the human genome was aligned to the mouse genome (using the tool LiftOver, <italic><ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgLiftOver">http://genome.ucsc.edu/cgi-bin/hgLiftOver</ext-link></italic>) after excision of all repetitive elements (performed with RepeatMasker, <italic><ext-link ext-link-type="uri" xlink:href="http://www.repeatmasker.org/">http://www.repeatmasker.org/</ext-link></italic>). Nothing informative was found by measuring the association of mouse H3K4me3 with these syntenic regions and comparing these values with those obtained using control loci.</p><p>P300 and H3K27ac bind intra-species conserved regions and co-localize in embryonic-specific enhancers [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B51">51</xref>]. These markers are also associated with HERV-H in human ES cells, lying within 4 kB of 80% of HERV-H proviruses (F score 0.95; p&#x02009;&#x0003c;&#x02009;10<sup>-300</sup>). It seems unlikely that an exogenous retrovirus would be capable of recruiting these factors by exploiting random conserved regions around its integration site. This suggests that a pre-existing layer of epigenetic markers favored integration of HERV-H into particular host loci and that these features are still preserved millions of years later.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Among retroelements in the human genome, the endogenous gammaretrovirus HERV-H is extraordinary for its high level expression in embryonic stem cells, in which it makes up 2% of all polyadenylated RNA. The human genome has ~1,000 copies of HERV-H, and the majority of the HERV-H RNA is encoded by a subset of 50 of these. HERV-H expression decreases as ES cells lose pluripotency, to the point where its expression is undetectable in fibroblasts. Consistent with this expression pattern, HERV-H is also expressed to high level in many iPS cells, though expression in some iPS cells is more modest; this heterogeneity may reflect reported differences in the epigenetic profile of many iPS cells, when compared with ES cells [<xref ref-type="bibr" rid="B29">29</xref>]. This suggests, then, that HERV-H RNA offers a relatively stringent marker for human pluripotency that would be worth monitoring during the generation of new iPS lines. The HERV-H RNAs in ES cells average about 5 kB in length and encode no protein. It, therefore, seems likely that HERV-H RNA contributes to pluripotency by acting as a chromatin-associated structural element or by acting as a microRNA decoy.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Statistical analysis of association between chromatin markers and retro-elements</title><p>Association with a given marker was defined as the presence of the endogenous proviral DNA within a fixed distance (usually 2 kilobases) from the nearest marker on the linear sequence of the chromosome. Unlike exogenous retroviruses, the endogenous virus is already integrated. Therefore, to restore the conditions before integration, the distance from the j-esim marker <italic>M</italic><sub><italic>j</italic></sub> with peaks in loci {<italic>m</italic><sub><italic>j</italic>0</sub>, &#x02026;, <italic>m</italic><sub><italic>jN</italic></sub>} and the i-esim provirus <italic>V</italic><sub><italic>i</italic></sub> spanning along the loci {<italic>V</italic><sub><italic>i</italic></sub><sup><italic>s</italic></sup>, <italic>V</italic><sub><italic>i</italic></sub><sup><italic>e</italic></sup>} has been calculated as</p><p><disp-formula><mml:math id="M1" name="1742-4690-9-111-i1" overflow="scroll"><mml:mrow><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mi>d</mml:mi><mml:mfenced open="(" close=")"><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mo>min</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mfenced open="|" close="|"><mml:mrow><mml:msup><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>s</mml:mi></mml:msup><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>,</mml:mo><mml:mfenced open="|" close="|"><mml:mrow><mml:msup><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>e</mml:mi></mml:msup><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="4.5em"/><mml:mo>=</mml:mo><mml:mo>min</mml:mo><mml:mfenced open="(" close=")"><mml:mfenced open="|" close="|"><mml:mrow><mml:msup><mml:msub><mml:mi>V</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>c</mml:mi></mml:msup><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mfenced><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi></mml:msubsup><mml:mo>&#x02212;</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:msubsup></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="M2" name="1742-4690-9-111-i2" overflow="scroll"><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mi>c</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi></mml:msubsup></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:math></inline-formula> is the central locus of the provirus.</p><p>As a control dataset, we randomly selected 100000 genomic locations. Association strength was measured with the statistical method based on the F score, as previously described in [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Formally the <italic>F</italic><sub><italic>&#x003b2;</italic></sub>-score is defined as the &#x003b2;-weighted harmonic mean of Precision(P) and Sensitivity(R): <inline-formula><mml:math id="M3" name="1742-4690-9-111-i3" overflow="scroll"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mi>&#x003b2;</mml:mi></mml:msub><mml:mo>&#x02261;</mml:mo><mml:mfenced open="(" close=")"><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mi>&#x003b2;</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfenced><mml:mfrac><mml:mtext mathvariant="italic">PR</mml:mtext><mml:mrow><mml:msup><mml:mi>&#x003b2;</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>R</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula>.</p><p>Here &#x003b2;&#x02009;=&#x02009;0.5 to give more weight to Precision than to Sensitivity. This balances type I and type II errors by adjusting for the high rate of False Positives inherent to the examination of large datasets for genome-wide binding sites according to statistical significance (F score based statistics and comparison with other measures have been extensively discussed in [<xref ref-type="bibr" rid="B18">18</xref>]).</p><p>Markers with F scores ranging between 0.5 and 1 were considered to be associated with endogenous integration sites.</p></sec><sec><title>RNASeq data analysis</title><p>HERV-H is present in more than 1000 &#x0201c;imperfect&#x0201d; copies in the human genome and its transcripts share a number of short conserved regions (each around 100 bp). Therefore, deep sequencing of those transcripts yields reads (25-75 bp long sequences) which perfectly align to several genomic loci. Indeed, multireads mapping is still a challenging process [<xref ref-type="bibr" rid="B52">52</xref>]. The strategy adopted here was to perform the alignment of uniquely mapped single- and paired-end reads and to reassign the multiple-mapped reads in function of the expression level of the surrounding (context) region [<xref ref-type="bibr" rid="B26">26</xref>]. HERV-H expression was evaluated in term of &#x0201c;Reads Per Kilobase per Million mapped reads (RPKM)&#x0201d; with the standard formula <inline-formula><mml:math id="M4" name="1742-4690-9-111-i4" overflow="scroll"><mml:mrow><mml:msub><mml:mi>E</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>K</mml:mi><mml:mfrac><mml:msub><mml:mi>N</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mi>r</mml:mi></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mi>T</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula>[<xref ref-type="bibr" rid="B53">53</xref>] where <italic>N</italic><sub><italic>r</italic></sub> is the number of reads mapping onto the <italic>r</italic> transcript, <italic>L</italic><sub><italic>r</italic></sub> is the length (in kB) of the <italic>r</italic><italic>esim</italic> transcript and <italic>N</italic><sub><italic>T</italic></sub> is the total number of reads <italic>K</italic>&#x02009;=&#x02009;10<sup>6</sup>.</p><p>Alignments of RNASeq generated reads have been performed with a two-step procedure. First we used <italic>Bowtie</italic>[<xref ref-type="bibr" rid="B54">54</xref>] on raw data, admitting up to two mismatches for each alignment, and then we discriminated between unique mapping reads and multireads, 80% and 20% of the total number of reads respectively. As expected, many multireads matched with repeated elements. Ignoring them would have resulted in a potential underestimation of the expression of endogenous retroviruses and, in general, of all repetitive elements. Therefore, we adopted a probabilistic assignment based on the amount of reads that univocally map onto the surrounding regions (context), as described in more detail in the next paragraph. This evaluation is also useful to establish if a repeated element is expressly transcribed or if it is part of another structure (i.e. a gene).</p></sec><sec><title>Probabilistic alignment of multiple mapping reads</title><p>The <italic>uniquely mapping read</italic> was defined as a short sequence generated by high throughput sequencing that can be aligned to a single genomic region <italic>s</italic>. Accordingly, we defined the <italic>multiread</italic> as a sequence <italic>r</italic> that aligns to a set of M regions {S<sub>1</sub>,&#x02026;,S<sub>M</sub>}. For each region <italic>s</italic><sub><italic>i</italic></sub> the <italic>context region</italic> is <italic>c</italic><sub><italic>i</italic></sub>&#x02009;=&#x02009;<italic>C</italic><sub><italic>i</italic></sub>/(<italic>C</italic><sub><italic>i</italic></sub> &#x02229; <italic>s</italic><sub><italic>i</italic></sub>) being <italic>C</italic><sub><italic>i</italic></sub> a genomic region of <italic>n</italic> nucleotides encompassing <italic>s</italic><sub><italic>i</italic></sub>. The assumption that the amount of reads is proportional to the amount of actual mRNA implies that the set of multireads is distributed on the reference genome accordingly to the amount of uniquely mapping reads aligned to the context regions. Consider <inline-formula><mml:math id="M5" name="1742-4690-9-111-i5" overflow="scroll"><mml:mrow><mml:msub><mml:mi mathvariant="fraktur">R</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced></mml:mrow></mml:math></inline-formula> as the function giving the number of reads of the dataset D that map univocally to the genomic region s described by the tuple (<italic>chr</italic>, <italic>start</italic>, <italic>end</italic>). Therefore, the probability of the read <italic>r</italic> to be actually part of the mRNA generated from the region <italic>s</italic><sub><italic>i</italic></sub> is estimated as:</p><p><disp-formula><mml:math id="M6" name="1742-4690-9-111-i6" overflow="scroll"><mml:mrow><mml:msub><mml:mi>P</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mfenced open="(" close=")"><mml:mrow><mml:mi>r</mml:mi><mml:mo>&#x02208;</mml:mo><mml:msub><mml:mi>s</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="fraktur">R</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mfenced open="(" close=")"><mml:msub><mml:mi>c</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mstyle displaystyle="true"><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mi>j</mml:mi><mml:mi>M</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mi mathvariant="fraktur">R</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mfenced open="(" close=")"><mml:msub><mml:mi>c</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mstyle></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p>Eventually, the set of multireads mapping to the same M regions is then partitioned to {S<sub>1</sub>,&#x02026;,S<sub>M</sub>} accordingly to <italic>P</italic><sub><italic>D</italic></sub> (<italic>s</italic><sub><italic>i</italic></sub>).</p></sec><sec><title>Specificity</title><p>The first axiom of high throughput sequencing asserts that the number of reads aligned to a specific genomic region is proportional to how much RNA has been generated by this region within the cell. At this point it is worth observing that repeated element (RE) sequences might be present in the RNA just because they are part of longer mRNAs.</p><p>Since we expect that elements having a specific biological function are independently transcribed, we attempted to distinguish between RE specifically expressed with their own promoter from those that are part of longer RNAs. The number of reads mapped to a region <italic>s</italic> can be naively modeled as a linear combination of <italic>specific reads T</italic>(<italic>s</italic>), <italic>unspecific reads U</italic>(<italic>s</italic>) and additional zero-mean <italic>noise</italic> &#x003c3;<sup>2</sup> that account for all other experimental and non-systematic fluctuations that can randomly influence the output of the sequencing process. Formally:</p><p><disp-formula><mml:math id="M7" name="1742-4690-9-111-i7" overflow="scroll"><mml:mrow><mml:mi mathvariant="fraktur">R</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mi>U</mml:mi><mml:mfenced open="(" close=")"><mml:mi>S</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:msup><mml:mi>&#x003c3;</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:math></disp-formula></p><p>where <inline-formula><mml:math id="M8" name="1742-4690-9-111-i8" overflow="scroll"><mml:mrow><mml:mi mathvariant="fraktur">R</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced></mml:mrow></mml:math></inline-formula>, as before, is the function giving the number of reads assigned to the region <italic>s</italic>.</p><p>Therefore, the mean number of reads in the region <italic>s</italic> is:</p><p><disp-formula><mml:math id="M9" name="1742-4690-9-111-i9" overflow="scroll"><mml:mrow><mml:mi>E</mml:mi><mml:mfenced open="[" close="]"><mml:mrow><mml:mi>T</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant="fraktur">R</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced><mml:mo>&#x02212;</mml:mo><mml:mi>U</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p><p>In order to estimate <italic>U</italic>(<italic>s</italic>), it is possible to count the number of reads mapped to the context region <italic>c</italic> as previously shown. Therefore we set</p><p><disp-formula><mml:math id="M10" name="1742-4690-9-111-i10" overflow="scroll"><mml:mrow><mml:mi>U</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="fraktur">R</mml:mi><mml:mfenced open="(" close=")"><mml:mi>c</mml:mi></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula></p><p>and we eventually adopt the following approximation to correct for the non-specificity of transcription:</p><p><disp-formula><mml:math id="M11" name="1742-4690-9-111-i11" overflow="scroll"><mml:mrow><mml:mi>E</mml:mi><mml:mfenced open="[" close="]"><mml:mrow><mml:mi>T</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>&#x02245;</mml:mo><mml:mi mathvariant="fraktur">R</mml:mi><mml:mfenced open="(" close=")"><mml:mi>s</mml:mi></mml:mfenced><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="fraktur">R</mml:mi><mml:mfenced open="(" close=")"><mml:mi>c</mml:mi></mml:mfenced></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:math></disp-formula></p></sec></sec><sec><title>Abbreviations</title><p>HERV: Human endogenous retrovirus; ES: Embryonic stem; iPS: Induced pluripotent stem; LTR: Long terminal repeat; lncRNA: Long non-coding RNA.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>FS and JL conceived and designed the experiments. FS, JG, and JL analyzed the data. FS and JL wrote the paper. All authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>The authors wish to thank Audrey Letourneau and Stylianos Antonarakis for providing unpublished RNA-seq data. This work was supported by NIDA/NIH/USA Grant DP1DA034990 and Swiss National Science Foundation grant 3100A0-128655 to J.L.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Stoye</surname><given-names>JP</given-names></name><article-title>Studies of endogenous retroviruses reveal a continuing evolutionary saga</article-title><source>Nat Rev Microbiol</source><year>2012</year><volume>10</volume><fpage>395</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">22565131</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Weiss</surname><given-names>RA</given-names></name><article-title>The discovery of endogenous retroviruses</article-title><source>Retrovirology</source><year>2006</year><volume>3</volume><fpage>67</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-3-67</pub-id><pub-id pub-id-type="pmid">17018135</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Subramanian</surname><given-names>RP</given-names></name><name><surname>Wildschutte</surname><given-names>JH</given-names></name><name><surname>Russo</surname><given-names>C</given-names></name><name><surname>Coffin</surname><given-names>JM</given-names></name><article-title>Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses</article-title><source>Retrovirology</source><year>2011</year><volume>8</volume><fpage>90</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-8-90</pub-id><pub-id pub-id-type="pmid">22067224</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Stengel</surname><given-names>A</given-names></name><name><surname>Roos</surname><given-names>C</given-names></name><name><surname>Hunsmann</surname><given-names>G</given-names></name><name><surname>Seifarth</surname><given-names>W</given-names></name><name><surname>Leib-Mosch</surname><given-names>C</given-names></name><name><surname>Greenwood</surname><given-names>AD</given-names></name><article-title>Expression profiles of endogenous retroviruses in Old World monkeys</article-title><source>J Virol</source><year>2006</year><volume>80</volume><fpage>4415</fpage><lpage>4421</lpage><pub-id pub-id-type="doi">10.1128/JVI.80.9.4415-4421.2006</pub-id><pub-id pub-id-type="pmid">16611901</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Mi</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Veldman</surname><given-names>GM</given-names></name><name><surname>Finnerty</surname><given-names>H</given-names></name><name><surname>Racie</surname><given-names>L</given-names></name><name><surname>LaVallie</surname><given-names>E</given-names></name><name><surname>Tang</surname><given-names>XY</given-names></name><name><surname>Edouard</surname><given-names>P</given-names></name><name><surname>Howes</surname><given-names>S</given-names></name><etal/><article-title>Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>785</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/35001608</pub-id><pub-id pub-id-type="pmid">10693809</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Vargas</surname><given-names>A</given-names></name><name><surname>Moreau</surname><given-names>J</given-names></name><name><surname>Landry</surname><given-names>S</given-names></name><name><surname>LeBellego</surname><given-names>F</given-names></name><name><surname>Toufaily</surname><given-names>C</given-names></name><name><surname>Rassart</surname><given-names>E</given-names></name><name><surname>Lafond</surname><given-names>J</given-names></name><name><surname>Barbeau</surname><given-names>B</given-names></name><article-title>Syncytin-2 plays an important role in the fusion of human trophoblast cells</article-title><source>J Mol Biol</source><year>2009</year><volume>392</volume><fpage>301</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2009.07.025</pub-id><pub-id pub-id-type="pmid">19616006</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Mangeney</surname><given-names>M</given-names></name><name><surname>Renard</surname><given-names>M</given-names></name><name><surname>Schlecht-Louf</surname><given-names>G</given-names></name><name><surname>Bouallaga</surname><given-names>I</given-names></name><name><surname>Heidmann</surname><given-names>O</given-names></name><name><surname>Letzelter</surname><given-names>C</given-names></name><name><surname>Richaud</surname><given-names>A</given-names></name><name><surname>Ducos</surname><given-names>B</given-names></name><name><surname>Heidmann</surname><given-names>T</given-names></name><article-title>Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>20534</fpage><lpage>20539</lpage><pub-id pub-id-type="doi">10.1073/pnas.0707873105</pub-id><pub-id pub-id-type="pmid">18077339</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="book"><name><surname>Coffin</surname><given-names>J</given-names></name><name><surname>Hughes</surname><given-names>S</given-names></name><name><surname>Varmus</surname><given-names>H</given-names></name><source>Retroviruses</source><year>1997</year><publisher-name>Cold Spring Harbor Laboratory Press, New York</publisher-name></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Muster</surname><given-names>T</given-names></name><name><surname>Waltenberger</surname><given-names>A</given-names></name><name><surname>Grassauer</surname><given-names>A</given-names></name><name><surname>Hirschl</surname><given-names>S</given-names></name><name><surname>Caucig</surname><given-names>P</given-names></name><name><surname>Romirer</surname><given-names>I</given-names></name><name><surname>Fodinger</surname><given-names>D</given-names></name><name><surname>Seppele</surname><given-names>H</given-names></name><name><surname>Schanab</surname><given-names>O</given-names></name><name><surname>Magin-Lachmann</surname><given-names>C</given-names></name><etal/><article-title>An endogenous retrovirus derived from human melanoma cells</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><fpage>8735</fpage><lpage>8741</lpage><pub-id pub-id-type="pmid">14695188</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Kolson</surname><given-names>DL</given-names></name><name><surname>Gonzalez-Scarano</surname><given-names>F</given-names></name><article-title>Endogenous retroviruses and multiple sclerosis</article-title><source>Ann Neurol</source><year>2001</year><volume>50</volume><fpage>429</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1002/ana.1235</pub-id><pub-id pub-id-type="pmid">11601492</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Nexo</surname><given-names>BA</given-names></name><name><surname>Christensen</surname><given-names>T</given-names></name><name><surname>Frederiksen</surname><given-names>J</given-names></name><name><surname>Moller-Larsen</surname><given-names>A</given-names></name><name><surname>Oturai</surname><given-names>AB</given-names></name><name><surname>Villesen</surname><given-names>P</given-names></name><name><surname>Hansen</surname><given-names>B</given-names></name><name><surname>Nissen</surname><given-names>KK</given-names></name><name><surname>Laska</surname><given-names>MJ</given-names></name><name><surname>Petersen</surname><given-names>TS</given-names></name><etal/><article-title>The etiology of multiple sclerosis: genetic evidence for the involvement of the human endogenous retrovirus HERV-Fc1</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e16652</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0016652</pub-id><pub-id pub-id-type="pmid">21311761</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Petersen</surname><given-names>T</given-names></name><name><surname>Moller-Larsen</surname><given-names>A</given-names></name><name><surname>Thiel</surname><given-names>S</given-names></name><name><surname>Brudek</surname><given-names>T</given-names></name><name><surname>Hansen</surname><given-names>TK</given-names></name><name><surname>Christensen</surname><given-names>T</given-names></name><article-title>Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis</article-title><source>J Neuroimmunol</source><year>2009</year><volume>215</volume><fpage>108</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.jneuroim.2009.08.015</pub-id><pub-id pub-id-type="pmid">19766328</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Karlsson</surname><given-names>H</given-names></name><name><surname>Schroder</surname><given-names>J</given-names></name><name><surname>Bachmann</surname><given-names>S</given-names></name><name><surname>Bottmer</surname><given-names>C</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name><article-title>HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder</article-title><source>Mol Psychiatry</source><year>2004</year><volume>9</volume><fpage>12</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/sj.mp.4001439</pub-id><pub-id pub-id-type="pmid">14571258</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Young</surname><given-names>GR</given-names></name><name><surname>Eksmond</surname><given-names>U</given-names></name><name><surname>Salcedo</surname><given-names>R</given-names></name><name><surname>Alexopoulou</surname><given-names>L</given-names></name><name><surname>Stoye</surname><given-names>JP</given-names></name><name><surname>Kassiotis</surname><given-names>G</given-names></name><article-title>Resurrection of endogenous retroviruses in antibody-deficient mice</article-title><source>Nature</source><year>2012</year><volume>491</volume><fpage>774</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">23103862</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Garrison</surname><given-names>KE</given-names></name><name><surname>Jones</surname><given-names>RB</given-names></name><name><surname>Meiklejohn</surname><given-names>DA</given-names></name><name><surname>Anwar</surname><given-names>N</given-names></name><name><surname>Ndhlovu</surname><given-names>LC</given-names></name><name><surname>Chapman</surname><given-names>JM</given-names></name><name><surname>Erickson</surname><given-names>AL</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Spotts</surname><given-names>G</given-names></name><name><surname>Hecht</surname><given-names>FM</given-names></name><etal/><article-title>T cell responses to human endogenous retroviruses in HIV-1 infection</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>e165</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.0030165</pub-id><pub-id pub-id-type="pmid">17997601</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>SenGupta</surname><given-names>D</given-names></name><name><surname>Tandon</surname><given-names>R</given-names></name><name><surname>Vieira</surname><given-names>RG</given-names></name><name><surname>Ndhlovu</surname><given-names>LC</given-names></name><name><surname>Lown-Hecht</surname><given-names>R</given-names></name><name><surname>Ormsby</surname><given-names>CE</given-names></name><name><surname>Loh</surname><given-names>L</given-names></name><name><surname>Jones</surname><given-names>RB</given-names></name><name><surname>Garrison</surname><given-names>KE</given-names></name><name><surname>Martin</surname><given-names>JN</given-names></name><etal/><article-title>Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection</article-title><source>J Virol</source><year>2011</year><volume>85</volume><fpage>6977</fpage><lpage>6985</lpage><pub-id pub-id-type="doi">10.1128/JVI.00179-11</pub-id><pub-id pub-id-type="pmid">21525339</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>van der Kuyl</surname><given-names>AC</given-names></name><article-title>HIV infection and HERV expression: a review</article-title><source>Retrovirology</source><year>2012</year><volume>9</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-9-6</pub-id><pub-id pub-id-type="pmid">22248111</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Santoni</surname><given-names>FA</given-names></name><name><surname>Hartley</surname><given-names>O</given-names></name><name><surname>Luban</surname><given-names>J</given-names></name><article-title>Deciphering the code for retroviral integration target site selection</article-title><source>PLoS Comput Biol</source><year>2010</year><volume>6</volume><fpage>e1001008</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1001008</pub-id><pub-id pub-id-type="pmid">21124862</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="other"><name><surname>Santoni</surname><given-names>FA</given-names></name><article-title>EMdeCODE: a novel algorithm capable of reading words of epigenetic code to predict enhancers and retroviral integration sites and to identify H3R2me1 as a distinctive mark of coding versus non-coding genes</article-title><source>Nucl Acid Res</source><year>2012</year><comment>in press</comment></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Hawkins</surname><given-names>RD</given-names></name><name><surname>Hon</surname><given-names>GC</given-names></name><name><surname>Lee</surname><given-names>LK</given-names></name><name><surname>Ngo</surname><given-names>Q</given-names></name><name><surname>Lister</surname><given-names>R</given-names></name><name><surname>Pelizzola</surname><given-names>M</given-names></name><name><surname>Edsall</surname><given-names>LE</given-names></name><name><surname>Kuan</surname><given-names>S</given-names></name><name><surname>Luu</surname><given-names>Y</given-names></name><name><surname>Klugman</surname><given-names>S</given-names></name><etal/><article-title>Distinct epigenomic landscapes of pluripotent and lineage-committed human cells</article-title><source>Cell Stem Cell</source><year>2010</year><volume>6</volume><fpage>479</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.03.018</pub-id><pub-id pub-id-type="pmid">20452322</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Guenther</surname><given-names>MG</given-names></name><name><surname>Frampton</surname><given-names>GM</given-names></name><name><surname>Soldner</surname><given-names>F</given-names></name><name><surname>Hockemeyer</surname><given-names>D</given-names></name><name><surname>Mitalipova</surname><given-names>M</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name><article-title>Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells</article-title><source>Cell Stem Cell</source><year>2010</year><volume>7</volume><fpage>249</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.06.015</pub-id><pub-id pub-id-type="pmid">20682450</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Robertson</surname><given-names>G</given-names></name><name><surname>Hirst</surname><given-names>M</given-names></name><name><surname>Bainbridge</surname><given-names>M</given-names></name><name><surname>Bilenky</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>T</given-names></name><name><surname>Euskirchen</surname><given-names>G</given-names></name><name><surname>Bernier</surname><given-names>B</given-names></name><name><surname>Varhol</surname><given-names>R</given-names></name><name><surname>Delaney</surname><given-names>A</given-names></name><etal/><article-title>Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing</article-title><source>Nat Methods</source><year>2007</year><volume>4</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/nmeth1068</pub-id><pub-id pub-id-type="pmid">17558387</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name><name><surname>Costello</surname><given-names>JF</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Milosavljevic</surname><given-names>A</given-names></name><name><surname>Meissner</surname><given-names>A</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>Beaudet</surname><given-names>AL</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><etal/><article-title>The NIH roadmap epigenomics mapping consortium</article-title><source>Nat Biotechnol</source><year>2010</year><volume>28</volume><fpage>1045</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1038/nbt1010-1045</pub-id><pub-id pub-id-type="pmid">20944595</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Kunarso</surname><given-names>G</given-names></name><name><surname>Chia</surname><given-names>NY</given-names></name><name><surname>Jeyakani</surname><given-names>J</given-names></name><name><surname>Hwang</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Chan</surname><given-names>YS</given-names></name><name><surname>Ng</surname><given-names>HH</given-names></name><name><surname>Bourque</surname><given-names>G</given-names></name><article-title>Transposable elements have rewired the core regulatory network of human embryonic stem cells</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>631</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1038/ng.600</pub-id><pub-id pub-id-type="pmid">20526341</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Lister</surname><given-names>R</given-names></name><name><surname>Pelizzola</surname><given-names>M</given-names></name><name><surname>Dowen</surname><given-names>RH</given-names></name><name><surname>Hawkins</surname><given-names>RD</given-names></name><name><surname>Hon</surname><given-names>G</given-names></name><name><surname>Tonti-Filippini</surname><given-names>J</given-names></name><name><surname>Nery</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Ngo</surname><given-names>QM</given-names></name><etal/><article-title>Human DNA methylomes at base resolution show widespread epigenomic differences</article-title><source>Nature</source><year>2009</year><volume>462</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/nature08514</pub-id><pub-id pub-id-type="pmid">19829295</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>JQ</given-names></name><name><surname>Habegger</surname><given-names>L</given-names></name><name><surname>Noisa</surname><given-names>P</given-names></name><name><surname>Szekely</surname><given-names>A</given-names></name><name><surname>Qiu</surname><given-names>C</given-names></name><name><surname>Hutchison</surname><given-names>S</given-names></name><name><surname>Raha</surname><given-names>D</given-names></name><name><surname>Egholm</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Weissman</surname><given-names>S</given-names></name><etal/><article-title>Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>5254</fpage><lpage>5259</lpage><pub-id pub-id-type="doi">10.1073/pnas.0914114107</pub-id><pub-id pub-id-type="pmid">20194744</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Adli</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><article-title>Genome-wide chromatin maps derived from limited numbers of hematopoietic progenitors</article-title><source>Nat Methods</source><year>2010</year><volume>7</volume><fpage>615</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1478</pub-id><pub-id pub-id-type="pmid">20622861</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Ku</surname><given-names>M</given-names></name><name><surname>Jaffe</surname><given-names>DB</given-names></name><name><surname>Issac</surname><given-names>B</given-names></name><name><surname>Lieberman</surname><given-names>E</given-names></name><name><surname>Giannoukos</surname><given-names>G</given-names></name><name><surname>Alvarez</surname><given-names>P</given-names></name><name><surname>Brockman</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>TK</given-names></name><name><surname>Koche</surname><given-names>RP</given-names></name><etal/><article-title>Genome-wide maps of chromatin state in pluripotent and lineage-committed cells</article-title><source>Nature</source><year>2007</year><volume>448</volume><fpage>553</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1038/nature06008</pub-id><pub-id pub-id-type="pmid">17603471</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Bock</surname><given-names>C</given-names></name><name><surname>Kiskinis</surname><given-names>E</given-names></name><name><surname>Verstappen</surname><given-names>G</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Boulting</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>ZD</given-names></name><name><surname>Ziller</surname><given-names>M</given-names></name><name><surname>Croft</surname><given-names>GF</given-names></name><name><surname>Amoroso</surname><given-names>MW</given-names></name><name><surname>Oakley</surname><given-names>DH</given-names></name><etal/><article-title>Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines</article-title><source>Cell</source><year>2011</year><volume>144</volume><fpage>439</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.12.032</pub-id><pub-id pub-id-type="pmid">21295703</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Ruthenburg</surname><given-names>AJ</given-names></name><name><surname>Allis</surname><given-names>CD</given-names></name><name><surname>Wysocka</surname><given-names>J</given-names></name><article-title>Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark</article-title><source>Mol Cell</source><year>2007</year><volume>25</volume><fpage>15</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2006.12.014</pub-id><pub-id pub-id-type="pmid">17218268</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Barski</surname><given-names>A</given-names></name><name><surname>Cuddapah</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>K</given-names></name><name><surname>Roh</surname><given-names>TY</given-names></name><name><surname>Schones</surname><given-names>DE</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Chepelev</surname><given-names>I</given-names></name><name><surname>Zhao</surname><given-names>K</given-names></name><article-title>High-resolution profiling of histone methylations in the human genome</article-title><source>Cell</source><year>2007</year><volume>129</volume><fpage>823</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.05.009</pub-id><pub-id pub-id-type="pmid">17512414</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Mikkelsen</surname><given-names>TS</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Kamal</surname><given-names>M</given-names></name><name><surname>Huebert</surname><given-names>DJ</given-names></name><name><surname>Cuff</surname><given-names>J</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Meissner</surname><given-names>A</given-names></name><name><surname>Wernig</surname><given-names>M</given-names></name><name><surname>Plath</surname><given-names>K</given-names></name><etal/><article-title>A bivalent chromatin structure marks key developmental genes in embryonic stem cells</article-title><source>Cell</source><year>2006</year><volume>125</volume><fpage>315</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.02.041</pub-id><pub-id pub-id-type="pmid">16630819</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Celniker</surname><given-names>SE</given-names></name><name><surname>Dillon</surname><given-names>LA</given-names></name><name><surname>Gerstein</surname><given-names>MB</given-names></name><name><surname>Gunsalus</surname><given-names>KC</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name><name><surname>Karpen</surname><given-names>GH</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>EC</given-names></name><name><surname>Lieb</surname><given-names>JD</given-names></name><name><surname>MacAlpine</surname><given-names>DM</given-names></name><etal/><article-title>Unlocking the secrets of the genome</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>927</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1038/459927a</pub-id><pub-id pub-id-type="pmid">19536255</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Rada-Iglesias</surname><given-names>A</given-names></name><name><surname>Bajpai</surname><given-names>R</given-names></name><name><surname>Swigut</surname><given-names>T</given-names></name><name><surname>Brugmann</surname><given-names>SA</given-names></name><name><surname>Flynn</surname><given-names>RA</given-names></name><name><surname>Wysocka</surname><given-names>J</given-names></name><article-title>A unique chromatin signature uncovers early developmental enhancers in humans</article-title><source>Nature</source><year>2011</year><volume>470</volume><fpage>279</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1038/nature09692</pub-id><pub-id pub-id-type="pmid">21160473</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Tada</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>M</given-names></name><article-title>Toti-/pluripotential stem cells and epigenetic modifications</article-title><source>Cell Struct Funct</source><year>2001</year><volume>26</volume><fpage>149</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1247/csf.26.149</pub-id><pub-id pub-id-type="pmid">11565807</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name><article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title><source>Cell</source><year>2006</year><volume>126</volume><fpage>663</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2006.07.024</pub-id><pub-id pub-id-type="pmid">16904174</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Vodyanik</surname><given-names>MA</given-names></name><name><surname>Smuga-Otto</surname><given-names>K</given-names></name><name><surname>Antosiewicz-Bourget</surname><given-names>J</given-names></name><name><surname>Frane</surname><given-names>JL</given-names></name><name><surname>Tian</surname><given-names>S</given-names></name><name><surname>Nie</surname><given-names>J</given-names></name><name><surname>Jonsdottir</surname><given-names>GA</given-names></name><name><surname>Ruotti</surname><given-names>V</given-names></name><name><surname>Stewart</surname><given-names>R</given-names></name><etal/><article-title>Induced pluripotent stem cell lines derived from human somatic cells</article-title><source>Science</source><year>2007</year><volume>318</volume><fpage>1917</fpage><lpage>1920</lpage><pub-id pub-id-type="doi">10.1126/science.1151526</pub-id><pub-id pub-id-type="pmid">18029452</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Chambers</surname><given-names>I</given-names></name><name><surname>Silva</surname><given-names>J</given-names></name><name><surname>Colby</surname><given-names>D</given-names></name><name><surname>Nichols</surname><given-names>J</given-names></name><name><surname>Nijmeijer</surname><given-names>B</given-names></name><name><surname>Robertson</surname><given-names>M</given-names></name><name><surname>Vrana</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>K</given-names></name><name><surname>Grotewold</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><article-title>Nanog safeguards pluripotency and mediates germline development</article-title><source>Nature</source><year>2007</year><volume>450</volume><fpage>1230</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1038/nature06403</pub-id><pub-id pub-id-type="pmid">18097409</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Mitsui</surname><given-names>K</given-names></name><name><surname>Tokuzawa</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><name><surname>Segawa</surname><given-names>K</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Maruyama</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Yamanaka</surname><given-names>S</given-names></name><article-title>The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells</article-title><source>Cell</source><year>2003</year><volume>113</volume><fpage>631</fpage><lpage>642</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00393-3</pub-id><pub-id pub-id-type="pmid">12787504</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Boiani</surname><given-names>M</given-names></name><name><surname>Scholer</surname><given-names>HR</given-names></name><article-title>Regulatory networks in embryo-derived pluripotent stem cells</article-title><source>Nat Rev Mol Cell Biol</source><year>2005</year><volume>6</volume><fpage>872</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1038/nrm1744</pub-id><pub-id pub-id-type="pmid">16227977</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Boyer</surname><given-names>LA</given-names></name><name><surname>Lee</surname><given-names>TI</given-names></name><name><surname>Cole</surname><given-names>MF</given-names></name><name><surname>Johnstone</surname><given-names>SE</given-names></name><name><surname>Levine</surname><given-names>SS</given-names></name><name><surname>Zucker</surname><given-names>JP</given-names></name><name><surname>Guenther</surname><given-names>MG</given-names></name><name><surname>Kumar</surname><given-names>RM</given-names></name><name><surname>Murray</surname><given-names>HL</given-names></name><name><surname>Jenner</surname><given-names>RG</given-names></name><etal/><article-title>Core transcriptional regulatory circuitry in human embryonic stem cells</article-title><source>Cell</source><year>2005</year><volume>122</volume><fpage>947</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.08.020</pub-id><pub-id pub-id-type="pmid">16153702</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Cesana</surname><given-names>M</given-names></name><name><surname>Cacchiarelli</surname><given-names>D</given-names></name><name><surname>Legnini</surname><given-names>I</given-names></name><name><surname>Santini</surname><given-names>T</given-names></name><name><surname>Sthandier</surname><given-names>O</given-names></name><name><surname>Chinappi</surname><given-names>M</given-names></name><name><surname>Tramontano</surname><given-names>A</given-names></name><name><surname>Bozzoni</surname><given-names>I</given-names></name><article-title>A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA</article-title><source>Cell</source><year>2011</year><volume>147</volume><fpage>358</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.09.028</pub-id><pub-id pub-id-type="pmid">22000014</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Poliseno</surname><given-names>L</given-names></name><name><surname>Salmena</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Carver</surname><given-names>B</given-names></name><name><surname>Haveman</surname><given-names>WJ</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name><article-title>A coding-independent function of gene and pseudogene mRNAs regulates tumour biology</article-title><source>Nature</source><year>2010</year><volume>465</volume><fpage>1033</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1038/nature09144</pub-id><pub-id pub-id-type="pmid">20577206</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Tsai</surname><given-names>MC</given-names></name><name><surname>Manor</surname><given-names>O</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Mosammaparast</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>JK</given-names></name><name><surname>Lan</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Segal</surname><given-names>E</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><article-title>Long noncoding RNA as modular scaffold of histone modification complexes</article-title><source>Science</source><year>2010</year><volume>329</volume><fpage>689</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1126/science.1192002</pub-id><pub-id pub-id-type="pmid">20616235</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Tattermusch</surname><given-names>A</given-names></name><name><surname>Brockdorff</surname><given-names>N</given-names></name><article-title>A scaffold for X chromosome inactivation</article-title><source>Hum Genet</source><year>2011</year><volume>130</volume><fpage>247</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1007/s00439-011-1027-4</pub-id><pub-id pub-id-type="pmid">21660507</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Chaumeil</surname><given-names>J</given-names></name><name><surname>Le Baccon</surname><given-names>P</given-names></name><name><surname>Wutz</surname><given-names>A</given-names></name><name><surname>Heard</surname><given-names>E</given-names></name><article-title>A novel role for Xist RNA in the formation of a repressive nuclear compartment into which genes are recruited when silenced</article-title><source>Genes Dev</source><year>2006</year><volume>20</volume><fpage>2223</fpage><lpage>2237</lpage><pub-id pub-id-type="doi">10.1101/gad.380906</pub-id><pub-id pub-id-type="pmid">16912274</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Bromberg</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Konigsberg</surname><given-names>W</given-names></name><name><surname>Garen</surname><given-names>A</given-names></name><article-title>Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model</article-title><source>Proc Natl Acad Sci U S A</source><year>2002</year><volume>99</volume><fpage>6269</fpage><lpage>6273</lpage><pub-id pub-id-type="pmid">11959915</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Meric</surname><given-names>C</given-names></name><name><surname>Goff</surname><given-names>SP</given-names></name><article-title>Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein</article-title><source>J Virol</source><year>1989</year><volume>63</volume><fpage>1558</fpage><lpage>1568</lpage><pub-id pub-id-type="pmid">2926863</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Wolf</surname><given-names>D</given-names></name><name><surname>Goff</surname><given-names>SP</given-names></name><article-title>Embryonic stem cells use ZFP809 to silence retroviral DNAs</article-title><source>Nature</source><year>2009</year><volume>458</volume><fpage>1201</fpage><lpage>1204</lpage><pub-id pub-id-type="doi">10.1038/nature07844</pub-id><pub-id pub-id-type="pmid">19270682</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Wolf</surname><given-names>D</given-names></name><name><surname>Goff</surname><given-names>SP</given-names></name><article-title>TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells</article-title><source>Cell</source><year>2007</year><volume>131</volume><fpage>46</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.07.026</pub-id><pub-id pub-id-type="pmid">17923087</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Creyghton</surname><given-names>MP</given-names></name><name><surname>Cheng</surname><given-names>AW</given-names></name><name><surname>Welstead</surname><given-names>GG</given-names></name><name><surname>Kooistra</surname><given-names>T</given-names></name><name><surname>Carey</surname><given-names>BW</given-names></name><name><surname>Steine</surname><given-names>EJ</given-names></name><name><surname>Hanna</surname><given-names>J</given-names></name><name><surname>Lodato</surname><given-names>MA</given-names></name><name><surname>Frampton</surname><given-names>GM</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name><etal/><article-title>Histone H3K27ac separates active from poised enhancers and predicts developmental state</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>107</volume><fpage>21931</fpage><lpage>21936</lpage><pub-id pub-id-type="pmid">21106759</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Pepke</surname><given-names>S</given-names></name><name><surname>Wold</surname><given-names>B</given-names></name><name><surname>Mortazavi</surname><given-names>A</given-names></name><article-title>Computation for ChIP-seq and RNA-seq studies</article-title><source>Nat Methods</source><year>2009</year><volume>6</volume><fpage>S22</fpage><lpage>S32</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1371</pub-id><pub-id pub-id-type="pmid">19844228</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Mortazavi</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>McCue</surname><given-names>K</given-names></name><name><surname>Schaeffer</surname><given-names>L</given-names></name><name><surname>Wold</surname><given-names>B</given-names></name><article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title><source>Nat Methods</source><year>2008</year><volume>5</volume><fpage>621</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1226</pub-id><pub-id pub-id-type="pmid">18516045</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name><article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title><source>Genome Biol</source><year>2009</year><volume>10</volume><fpage>R25</fpage><pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id><pub-id pub-id-type="pmid">19261174</pub-id></mixed-citation></ref></ref-list></back></article>